CARDIOPROGRESS
Foundation for the advancement of cardiology

What's New in the AHA/ASA Secondary Stroke Prevention Guidelines? Clinical Context Risk for recurrent stroke or TIA is high but can be lowered by appropriate secondary stroke prevention. As secondary stroke prevention strategies have improved in recent years, cohort studies have shown decreased rates of recurrent stroke and transient ischemic attack (TIA).

ESC Congress 2021 ESC Congress is first and foremost a celebration of science. It's all about challenging and inspiring cardiovascular professionals to discover and deliver the best care possible to their patients. It’s widely regarded as THE annual cardiology event in the calendar.

COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link The American Heart Association (AHA) has issued new guidance for patients with hypertension during the COVID-19 outbreak. At the same time, several new review articles have been published further exploring the possible relationship between the renin-angiotensin system (RAS) and the virus.

СOVID-19 and cardiovascular disease: current articles

ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19) The bulletin provides background on the epidemic, which was first reported in late December 2019, and looks at early cardiac implications from case reports.

Eating An Egg A Day Is A-OK, Despite Heart Disease History, New Study Suggests Interest in high-protein and high-fat diets like the keto diet keeps growing, but concerns about the health effects of many foods on those diets remain high. For at least one of those foods—the simple protein-packed egg—a new, large-scale study suggests that devouring one a day is fine for most people, even those with a history of heart disease.

Marijuana may cause the same cardiovascular damage as cigarettes More than two million Americans with heart disease are using or have used marijuana - and it could put them at risk of dangerously heavy bleeding and other complications, a new study warns.

Don't Stop the Statin! Christopher P. Cannon Lipid lowering with statins is one of the most beneficial therapies in cardiovascular medicine, with evidence from hundreds of randomized clinical trials, including >25 large cardiovascular outcomes trials in the Cholesterol Treatment Trialists (CTT) collaboration.

Expert point of view Strategies to Overcome Residual Risk During Statins Era

PreHT 2020|Vilnius | Lithuania | 2-5 April 2020 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease (PreHT 2020)